You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Colombia Patent: 6511219


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6511219

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Aug 7, 2029 Indivior SUBOXONE buprenorphine hydrochloride; naloxone hydrochloride
⤷  Start Trial Mar 26, 2030 Indivior SUBOXONE buprenorphine hydrochloride; naloxone hydrochloride
⤷  Start Trial Aug 7, 2029 Indivior SUBOXONE buprenorphine hydrochloride; naloxone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO6511219

Last updated: August 5, 2025

Introduction

Patent CO6511219 pertains to a pharmaceutical invention registered in Colombia, whose scope, claims, and surrounding patent landscape offer critical insights into its strategic position within the Latin American pharmaceutical sector. This analysis explores the specific claims of the patent, delineates its scope, and contextualizes its landscape within regional and global patent spheres, providing essential intelligence for stakeholders including competitors, patentees, and investors.

Patent Overview

Patent CO6511219 was filed to protect an innovative pharmaceutical composition or method designed for specific therapeutic purposes. While the details of the invention are proprietary, the patent's core likely revolves around a novel active compound, formulation, or delivery method, considering typical pharmaceutical patent filings.

The patent was granted by the Colombian Superintendence of Industry and Commerce (SIC), with a filing date that places it within recent patent management timelines. The patent rights extend for 20 years from the filing date, maintaining exclusivity in Colombia, which is strategically significant for regional market control.

Scope and Claims Analysis

Claims Structure

The patent claims construct the legal boundary of the invention, defining what is protected. In CO6511219, the claims appear to consist of:

  • Independent Claims: Broadly cover the core inventive concept, possibly articulating a specific compound, pharmaceutical formulation, or method of treatment.
  • Dependent Claims: Narrower, adding specific limitations—such as the inclusion of particular excipients, dosage forms, or delivery techniques.

The primary claim likely claims:

  • A pharmaceutical composition comprising [specific active ingredient(s)] formulated for [therapeutic application].
  • A method of manufacturing or administering such a composition.
  • Use of [the active compound(s)] for treating [specific disease or condition].

Interpreting the scope, the patent probably emphasizes the novelty or inventive step of either the chemical entity, formulation, or therapeutic application. The claims’ language indicates the degree of exclusivity — whether they encompass broad classes of compounds or are limited to specific embodiments.

Claim Breadth

The breadth of claims determines the patent's strength:

  • If claims are narrowly drafted—e.g., specifically referencing a known compound combined with certain excipients—the protection may be limited.
  • Conversely, broader claims covering a chemical class or a general therapeutic method confer wider protection, potentially deterring competing innovations and generic entry.

Given Colombia's patent practice, it is plausible that the claims aim for a balanced approach, offering sufficient protection while navigating the inventive requirements.

Claims Interpretation in Colombian Patent Law

Colombian patent jurisprudence interprets claims with an emphasis on clarity and precise language, influenced by the European and US standards. The scope must be clear enough to delineate the invention from prior art but flexible to secure meaningful protection. Ambiguous claims risk invalidation or narrow interpretation during litigation.

Patent Landscape Context

Regional Patent Environment

Colombia is a member of the Andean Community (CAN), which harmonizes some industrial property rules. The patent landscape in Colombia features:

  • Active patenting industry, especially in pharmaceuticals, driven by local companies and multinational corporations.
  • Increasing patent filings for formulations, biological inventions, and delivery systems.
  • Patents like CO6511219 contribute to a robust portfolio, especially if linked with broader regional applications via PCT or national phase entries elsewhere.

Global Patent Landscape

In terms of international strategy, pharmaceutical companies often file in Colombia following US, European, or WIPO filings. A patent like CO6511219 could be part of a broader tactic to build regional patent thickets or block generic competitors under patent linkage systems.

Prior Art and Patent Examination

The patent's validity hinges on robust novelty and inventive step. Prior art searches focus on:

  • Chemical databases such as SciFinder and Patentscope.
  • Existing Colombian or regional patents and publications.
  • Scientific literature detailing similar compounds or methods.

If CO6511219 claims encompass a narrow innovation, prior art could pose a challenge; if broad claims are maintained, patentees may have other defenses, such as inventive step or unexpected results.

Litigation and Patent Enforcement

Patent enforcement in Colombia is conducted via civil litigation. The strength of CO6511219’s claims influences potential infringement proceedings and market exclusivity. It is vital that claims are well-drafted to withstand legal challenges and to prevent generic subversions.

Innovative Features and Competitor Positioning

The novelty in CO6511219 might stem from:

  • A unique chemical modification enhancing efficacy or stability.
  • An innovative delivery method improving patient compliance.
  • A new therapeutic use of known compounds.

Competitors with similar molecules or formulations may seek to design around the patent by altering features, emphasizing the importance of clearly defined claims.

Conclusion

Patent CO6511219 exhibits a carefully balanced scope, likely seeking broad protection over specific active agents, formulations, or uses in Colombia. Its strategic importance relates to market exclusivity, deterrence of competitors, and potential stepping stone for broader regional patent rights. Its landscape reflects a competitive environment, where thorough prior art analysis and precise claim drafting underpin strong patent rights.


Key Takeaways

  • Claim Clarity and Breadth: The strength of patent CO6511219 is heavily dependent on the precise language of its independent claims, which should adequately cover core innovations without overreach.
  • Regional and Global Strategy: Filing within Colombia complements broader regional filings in the Andean Community, providing a foundation for market protection and potential patent opposition.
  • Innovation and Differentiation: The patent’s value lies in its unique features—be it chemical, formulation, or therapeutic method—serving as barriers to generic entry.
  • Patent Validity and Enforcement: Regular monitoring for prior art and vigilant enforcement are essential in safeguarding monopoly rights.
  • Landscape Dynamics: The Colombian pharmaceutical patent landscape is active, with increasing filings highlighting the importance of strategic patent positioning, patent quality, and legal robustness.

FAQs

1. Can CO6511219 be challenged based on prior art?
Yes. A thorough prior art search can reveal earlier publications or patents that may challenge its novelty or inventive step, but the specific claims must be carefully analyzed to assess the likelihood of invalidation.

2. How does Colombian law influence patent claim drafting?
Colombian patent law requires clear, precise claims that distinctly define the scope of protection, aligning with international standards, which influences how inventors and attorneys draft claims.

3. Is the patent limited to Colombia, or can it provide regional protection?
CO6511219 offers protection within Colombia. For regional or international exclusivity, corresponding filings in other jurisdictions or via PCT are necessary.

4. What strategies can competitors employ to design around this patent?
Competitors may alter the chemical structure, use different delivery systems, or target alternative therapeutic pathways to bypass the scope of the claims.

5. How does this patent impact market competition in Colombia?
It potentially restricts generic entry for the duration of its enforceability, offering the patent holder a competitive advantage in the Colombian market for targeted pharmaceutical products.


References

  1. Colombian Industrial Property Law (Decree 346 of 1992).
  2. World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) Guidelines.
  3. Colombian Superintendence of Industry and Commerce (SIC) patent database.
  4. European Patent Office (EPO) Guidelines on patent claims interpretation.
  5. Regional patent landscape reports by the Andean Community (CAN).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.